AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial - PubMed
6 hours ago
- #AI in healthcare
- #mammography
- #breast cancer screening
- AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening was evaluated in a paired, noninferiority clinical trial.
- The trial included 31,301 women between March 2022 and January 2024, comparing standard double-blind reading with AI-supported screening.
- AI-supported screening reduced radiologist workload by 63.6% and increased the cancer detection rate by 15.2%, but recall rates were 14.8% higher.
- Subanalyses showed similar workload reductions in digital mammography (-62.1%) and digital breast tomosynthesis (-65.5%), with varying impacts on detection and recall rates.
- The study demonstrates the feasibility of a partially automated AI workflow in breast cancer screening, avoiding human reading of low-risk cases.